[HTML][HTML] A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients
S Kumar, SS Eranezhath, VK Vishwanathan… - Journal of Herbal …, 2024 - Elsevier
Introduction In hospitalised mild to moderate COVID-19 patients with pre-existing type 2
diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as
compared to standard of care (SOC) in ameliorating symptoms, avoiding the need for ICU
admission and ventilator support plus bringing down interleukin-6 (IL-6), and C-reactive
protein (CRP) over 15 days. Methods In this quasi-experimental trial, 24 participants per arm
diagnosed with COVID-19 by RT-PCR, aged 18–75 years, fulfilling the inclusion/exclusion …
diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as
compared to standard of care (SOC) in ameliorating symptoms, avoiding the need for ICU
admission and ventilator support plus bringing down interleukin-6 (IL-6), and C-reactive
protein (CRP) over 15 days. Methods In this quasi-experimental trial, 24 participants per arm
diagnosed with COVID-19 by RT-PCR, aged 18–75 years, fulfilling the inclusion/exclusion …
以上显示的是最相近的搜索结果。 查看全部搜索结果